Have you seen our new ‘How I treat…’ features? Become a member (it’s free!) and discover the latest advice from fellow clinicians here >>>

Coffee Chat: the unmet needs of the EGFR-positive NSCLC patient population

Available to watch now on demand

This Coffee Chat is intended for non-UK HCPs only.

Join our Coffee Chat focusing on patient needs in EGFR-mutant non-small-cell lung cancer (NSCLC). In particular, we will explore the current treatment options available, the unmet needs for patients with EGFR-positive lung cancer, as well as answer how we can meet these needs, the patient’s role and much more.

REGISTER NOWWhat will you learn?Who may this interest?Speakers

What will you learn?

  • What type of support do people with EGFR-positive NSCLC and their loved ones most often need?
  • How can we meet the unmet needs of patients living with EGFR-positive NSCLC?
  • What does the future of NSCLC treatment look like?
  • What role can pharmaceutical companies play in further supporting the lung cancer community?

Who may this interest?

  • Clinical Oncologists
  • Medical Oncologists
  • Surgical Oncologists
  • Regulatory bodies
  • Patients and advocate groups


Antonio Passaro

Antonio Passaro
Medical Oncologist

Division of Thoracic Oncology at the European Institute of Oncology (Milan, Italy)



Evert Walrave

Evert Walrave
Lung cancer caregiver

Member of Longkanker Nederland (Netherlands)



This Coffee Chat is intended for non-UK HCPs only.

Sponsored and funded by